Premium
Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation
Author(s) -
Woloschak Michael,
Yu Aiqin,
Post Kalmon D.
Publication year - 1997
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/(sici)1098-2744(199708)19:4<221::aid-mc1>3.0.co;2-f
Subject(s) - biology , gene , methylation , dna methylation , genetics , cancer research , gene expression
Rodent models of pituitary tumorigenesis have implicated the retinoblastoma (Rb) pathway in the development of pituitary tumors. Previously, we reported that loss of p16 expression rather than loss of Rb occurs in most human pituitary adenomas. This alteration in these tumors is not associated with p16 mutation or frequent homozygous p16 gene loss. Our laboratory has now demonstrated that in most human pituitary tumors, the 5′ CpG island of the p16 gene is extensively methylated. The high frequency of p16 gene methylation in human pituitary tumors suggests that this alteration is an early and perhaps required event in pituitary cell transformation. Mol. Carcinog. 19:221–224, 1997. © 1997 Wiley‐Liss, Inc.